Dopaminergic dysfunction in abstinent dexamphetamine users: results from a pharmacological fMRI study using a reward anticipation task and a methylphenidate challenge.
暂无分享,去创建一个
L. Reneman | W. Brink | A. Kaag | R. Lindauer | M. Schouw | M. B. Ruiter
[1] Brian Knutson,et al. Interactivity and Reward-Related Neural Activation during a Serious Videogame , 2012, PloS one.
[2] Sebastian Heinzel,et al. Association between reward‐related activation in the ventral striatum and trait reward sensitivity is moderated by dopamine transporter genotype , 2011, Human brain mapping.
[3] Marc N. Potenza,et al. An Initial Study of Neural Responses to Monetary Incentives as Related to Treatment Outcome in Cocaine Dependence , 2011, Biological Psychiatry.
[4] P. Liddle,et al. Task-related default mode network modulation and inhibitory control in ADHD: effects of motivation and methylphenidate. , 2011, Journal of child psychology and psychiatry, and allied disciplines.
[5] Mareike M. Menz,et al. Lower ventral striatal activation during reward anticipation in adolescent smokers. , 2011, The American journal of psychiatry.
[6] N. Volkow,et al. Addiction: Beyond dopamine reward circuitry , 2011, Proceedings of the National Academy of Sciences.
[7] Brian Knutson,et al. Reward processing in male adults with childhood ADHD—a comparison between drug-naïve and methylphenidate-treated subjects , 2011 .
[8] D. Hommer,et al. Imaging brain response to reward in addictive disorders , 2011, Annals of the New York Academy of Sciences.
[9] D. Zald,et al. Dopaminergic Network Differences in Human Impulsivity , 2010, Science.
[10] Ji-Kyung Choi,et al. Pharmacologic Neuroimaging of the Ontogeny of Dopamine Receptor Function , 2010, Developmental Neuroscience.
[11] Rita Z. Goldstein,et al. Striatal dopamine D2 receptor availability predicts the thalamic and medial prefrontal responses to reward in cocaine abusers three years later , 2010, Synapse.
[12] Rozmin Halari,et al. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task , 2009, Neuropharmacology.
[13] W. Pelham,et al. Effects of methylphenidate on discounting of delayed rewards in attention deficit/hyperactivity disorder. , 2009, Experimental and clinical psychopharmacology.
[14] Brian Knutson,et al. Ventral Striatal Activation During Reward Anticipation Correlates with Impulsivity in Alcoholics , 2009, Biological Psychiatry.
[15] J. Swanson,et al. Evaluating dopamine reward pathway in ADHD: clinical implications. , 2009, JAMA.
[16] S. Zysset,et al. Dopaminergic modulation of brain systems subserving decision making under uncertainty: A study with fMRI and methylphenidate challenge , 2009, Synapse.
[17] K. Lesch,et al. Neural Hyporesponsiveness and Hyperresponsiveness During Immediate and Delayed Reward Processing in Adult Attention-Deficit/Hyperactivity Disorder , 2009, Biological Psychiatry.
[18] W. van den Brink,et al. Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. , 2008, Brain : a journal of neurology.
[19] H. Gu,et al. The Effects of Methylphenidate on Knockin Mice with a Methylphenidate-Resistant Dopamine Transporter , 2008, Journal of Pharmacology and Experimental Therapeutics.
[20] R. Pasterkamp,et al. Getting connected in the dopamine system , 2008, Progress in Neurobiology.
[21] Michael Bauer,et al. Reward anticipation and outcomes in adult males with attention-deficit/hyperactivity disorder , 2008, NeuroImage.
[22] Brian Knutson,et al. Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholics , 2007, NeuroImage.
[23] Alain Dagher,et al. Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men. , 2006, Archives of general psychiatry.
[24] Nora D. Volkow,et al. Effects of expectation on the brain metabolic responses to methylphenidate and to its placebo in non-drug abusing subjects , 2006, NeuroImage.
[25] W. Barbaresi,et al. Psychostimulant treatment and risk for substance abuse among young adults with a history of attention-deficit/hyperactivity disorder: a population-based, birth cohort study. , 2005, Journal of child and adolescent psychopharmacology.
[26] U. McCann,et al. Amphetamine Treatment Similar to That Used in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder Damages Dopaminergic Nerve Endings in the Striatum of Adult Nonhuman Primates , 2005, Journal of Pharmacology and Experimental Therapeutics.
[27] Ali A. Bonab,et al. In Vivo Neuroreceptor Imaging in Attention-Deficit/Hyperactivity Disorder: A Focus on The Dopamine Transporter , 2005, Biological Psychiatry.
[28] P. C. Fletcher,et al. Abnormal frontal activations related to decision-making in current and former amphetamine and opiate dependent individuals , 2005, Psychopharmacology.
[29] A. L. Dixon,et al. Dopamine antagonist modulation of amphetamine response as detected using pharmacological MRI , 2005, Neuropharmacology.
[30] Ji-Kyung Choi,et al. Mapping interactions between dopamine and adenosine A2a receptors using pharmacologic MRI , 2005, Synapse.
[31] Jaap Oosterlaan,et al. The impact of reinforcement contingencies on AD/HD: a review and theoretical appraisal. , 2005, Clinical psychology review.
[32] Keith M. Shafritz,et al. The effects of methylphenidate on neural systems of attention in attention deficit hyperactivity disorder. , 2004, The American journal of psychiatry.
[33] Emily C. Bell,et al. Dextroamphetamine causes a change in regional brain activity in vivo during cognitive tasks: A functional magnetic resonance imaging study of blood oxygen level-dependent response , 2004, Biological Psychiatry.
[34] Brian Knutson,et al. Amphetamine Modulates Human Incentive Processing , 2004, Neuron.
[35] E. Bullmore,et al. Human pharmacological MRI. , 2004, Trends in pharmacological sciences.
[36] T. Wilens,et al. Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. , 2004, The Psychiatric clinics of North America.
[37] J. Swanson,et al. Serum and brain concentrations of methylphenidate: implications for use and abuse , 2003, Neuroscience & Biobehavioral Reviews.
[38] Stephen M. Smith,et al. General multilevel linear modeling for group analysis in FMRI , 2003, NeuroImage.
[39] Stephen M Smith,et al. Fast robust automated brain extraction , 2002, Human brain mapping.
[40] W. Schultz. Getting Formal with Dopamine and Reward , 2002, Neuron.
[41] Michael Brady,et al. Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images , 2002, NeuroImage.
[42] Brian Knutson,et al. Anticipation of Increasing Monetary Reward Selectively Recruits Nucleus Accumbens , 2001, The Journal of Neuroscience.
[43] B. Everitt,et al. Profiles of Cognitive Dysfunction in Chronic Amphetamine and Heroin Abusers , 2000, Neuropsychopharmacology.
[44] C. Halldin,et al. Changes in striatal D2‐receptor density following chronic treatment with amphetamine as assessed with pet in nonhuman primates , 1999, Synapse.
[45] G H Glover,et al. Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[46] D. Segal,et al. Behavioral alterations induced by an escalating dose-binge pattern of cocaine administration , 1997, Behavioural Brain Research.
[47] Sung-Cheng Huang,et al. Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey , 1997, Brain Research.
[48] D. Segal,et al. An Escalating Dose/Multiple High-Dose Binge Pattern of Amphetamine Administration Results in Differential Changes in the Extracellular Dopamine Response Profiles in Caudate-Putamen and Nucleus Accumbens , 1997, The Journal of Neuroscience.
[49] S. Strakowski,et al. Enhanced response to repeated d-amphetamine challenge: Evidence for behavioral sensitization in humans , 1996, Biological Psychiatry.
[50] M E Phelps,et al. 6‐[18F]fluoro‐L‐DOPA‐PETstudies show partial reversibility of long‐term effects of chronic amphetamine in monkeys , 1996, Synapse.
[51] W. McMahon,et al. Effects of methylphenidate on reward strength in boys with attention-deficit hyperactivity disorder. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.
[52] L. Seiden,et al. Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers , 1984, Brain Research.
[53] M. Trulson,et al. Cats develop tolerance to d-amphetamine's effects upon locomotion and stereotyped behaviors. , 1981, European Journal of Pharmacology.
[54] S. Haber,et al. The Reward Circuit: Linking Primate Anatomy and Human Imaging , 2010, Neuropsychopharmacology.
[55] Nikos Makris,et al. Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task. , 2008, Archives of general psychiatry.
[56] Jill U. Adams,et al. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. , 2008, Journal of the American Academy of Child and Adolescent Psychiatry.
[57] A. Scheres,et al. Temporal reward discounting and ADHD: task and symptom specific effects , 2007, Journal of Neural Transmission.
[58] R. Kivisaari,et al. Do individuals with former amphetamine dependence have cognitive deficits? , 2005, Nordic journal of psychiatry.
[59] W. van den Brink,et al. Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]β-CIT SPECT study – preliminary report , 2001, Psychopharmacology.
[60] D. Comings,et al. Reward deficiency syndrome: genetic aspects of behavioral disorders. , 2000, Progress in brain research.
[61] S. R. Nash,et al. Dopamine receptors: from structure to function. , 1998, Physiological reviews.